Description
TIRZEPATIDE INFORMATION (GLP-1 + GIP)
- BENEFITS
- Decreased appetite and cravings
- Weight loss
- Clinical trials showed 15% to 30% weight loss depending on doses
- Compounded formulas are compounded with medication to help alleviate side effects of nausea
- Injections are once weekly
- Can repeat program as many times as you wish
COMMON SIDE EFFECTS
- Nausea
- Constipation
- Indigestion
RISK OF THYROID C-CELL TUMORS
- If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take Semaglutide
INFORMATION
- Tirzepatide is a combination glucagon-like peptide 1 (GLP-1) receptor AND glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that acts on areas of brain that regulate food intake and appetite. 2,539 adult clinical trial showed weight loss from 15% to 35% weight loss versus placebo group.
